Answers are grounded in this paper and cite their sources.
Virus-like particles from a variety of RNA bacteriophages have turned out to be useful platforms for delivery of vaccine antigens in a highly immunogenic format. Here we update the current state of development of RNA phage VLPs as platforms for presentation of diverse antigens by genetic, enzymatic, and chemical display methods.
No takes yet. Share an insight, caveat, or question.
Peabody et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: